President of Mexico laments lack of vacancies to fire on Covid-19 in El Salvador | El Salvador News

The dictionaries of Andrés Manuel López Obrador ocurren cuando, según nifras nifras, El Salvador registra: 56 653 cases confirmed by Covid-19, y 1, 727 fallecidos por esa causa

The President of Mexico, Andrés Manuel López Obrador, lamented that Central American countries such as Guatemala, Honduras and El Salvador were not included in the vaccine against Covid-19.

“It is lamentable that Central American countries are affected, as are many other countries in the world, and that they have no access to the living space. Que Guatemala Honduras, El Salvador has no access to the vaccine. What is the vacancy required to protect these Germans? Pues nee, porque no es mucha la population. “I have a vision of solidarity and I have universal fraternity,” said López Obrador during his press conference.

You may be interested in: Gobierno pagó $ 12,600 in hospital in El Salvador for public presentations and revistas internacionales

The words of López Obrador show when, according to official figures, El Salvador registers: 56,653 confirmed cases of Covid-19, 1,727 bankruptcies for that reason and 3,927 active cases.

In addition, the Mexican mandate issued a letter to the International Community for “Thinking in Our Seeds” and allowing the vacancies to go to Central American countries. In the region, only Costa Rica and Panama have received, and applied, dose of Pfizer vaccine.

In the hope and sincerity of the departure of the vacancies

El Salvador is waiting for the arrival of different types of vehicles for the munitions against the Covid-19.

When the final decision was made in November of this year, the governor announced that there were millions of Provencal doses of the pharmaceutical company AstraZeneca, no information was given about the names of the other three companies, but about when he became a doctor in the country.

Lee also: Report sample saturation in hospital El Salvador

The vacancy of AstraZeneca and the University of Oxford has a minor cost and favorable conditions for grocery, transport and logistics, ahead of other competitors, as well as the alliance between the pharmaceutical firm Pfizer and the German BioNTech.

These are many more manufacturers and require a low temperature refrigeration that is difficult to commercialize and distribute all over the world at large levels.

.Source